Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Claude Roujeau

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Toxicology|March 16, 2005
Clinical heterogeneity of drug hypersensitivityJean-Claude Roujeau
Allergology International : Official Journal of the Japanese Society of Allergology|November 1, 2006
Immune mechanisms in drug allergyJean-Claude Roujeau
Drug Safety|January 19, 2013
Stevens-Johnson Syndrome and toxic epidermal necrolysis: improving the support to victimsJean-Claude Roujeau
La Revue Du Praticien|August 19, 2007
[Toxic epidermal necrolysis and Stevens-Johnson syndrome]Jean-Claude Roujeau
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 22, 2005
EMPACT syndromeMaja Mockenhaupt, Jean-Claude Roujeau
The Journal of Allergy and Clinical Immunology. in Practice|May 10, 2017
Virus Reactivation in Drug Reaction with Eosinophilia and Systemic Symptoms (Dress) Results from a Strong Drug-Specific Immune ResponseJean-Claude Roujeau, Nicolas Dupin
American Journal of Clinical Dermatology|July 17, 2003
Differential diagnosis of severe cutaneous drug eruptionsNicolas Bachot, Jean-Claude Roujeau
Current Opinion in Allergy and Clinical Immunology|July 17, 2003
Intravenous immunoglobulins in the treatment of severe drug eruptionsNicolas Bachot, Jean-Claude Roujeau
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 12, 2010
[Use of high dose intravenous immunoglobulins in dermatology]Maja Mockenhaupt, Jean-Claude Roujeau
Drugs|October 18, 2005
Treatment of epidermal necrolysis with high-dose intravenous immunoglobulins (IV Ig): clinical experience to dateOusmane Faye, Jean-Claude Roujeau
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Toxicology|March 16, 2005
Clinical heterogeneity of drug hypersensitivityJean-Claude Roujeau
Allergology International : Official Journal of the Japanese Society of Allergology|November 1, 2006
Immune mechanisms in drug allergyJean-Claude Roujeau
Drug Safety|January 19, 2013
Stevens-Johnson Syndrome and toxic epidermal necrolysis: improving the support to victimsJean-Claude Roujeau
La Revue Du Praticien|August 19, 2007
[Toxic epidermal necrolysis and Stevens-Johnson syndrome]Jean-Claude Roujeau
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 22, 2005
EMPACT syndromeMaja Mockenhaupt, Jean-Claude Roujeau
The Journal of Allergy and Clinical Immunology. in Practice|May 10, 2017
Virus Reactivation in Drug Reaction with Eosinophilia and Systemic Symptoms (Dress) Results from a Strong Drug-Specific Immune ResponseJean-Claude Roujeau, Nicolas Dupin
American Journal of Clinical Dermatology|July 17, 2003
Differential diagnosis of severe cutaneous drug eruptionsNicolas Bachot, Jean-Claude Roujeau
Current Opinion in Allergy and Clinical Immunology|July 17, 2003
Intravenous immunoglobulins in the treatment of severe drug eruptionsNicolas Bachot, Jean-Claude Roujeau
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 12, 2010
[Use of high dose intravenous immunoglobulins in dermatology]Maja Mockenhaupt, Jean-Claude Roujeau
Drugs|October 18, 2005
Treatment of epidermal necrolysis with high-dose intravenous immunoglobulins (IV Ig): clinical experience to dateOusmane Faye, Jean-Claude Roujeau
Pageof 10